Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
Tanya Jindal, Cindy Jiang, Omar Alhalabi, Charles B. Nguyen, Eugene Oh, Irene Tsung, Dimitra Rafailia Bakaloudi, Rafee Talukder, Matthew P. Davidsohn, Dory Freeman, Ilana Epstein, Chien‐Kuang Cornelia Ding, Amanda Nizam, Michael Glover, Ali Raza Khaki, Amy K. Taylor, Emily Lemke, Albert Jang, Sean T. Evans, Dongjun Shin, Cameron Pywell, Arnab Basu, Mehmet Asım Bilen, Yousef Zakharia, Pedro Barata, Matthew I. Milowsky, Jason R. Brown, Deepak Kilari, Hamid Emamekhoo, Christopher Hoimes, Sumit Shah, Nancy B. Davis, Shilpa Gupta, Petros Grivas, Joaquim Bellmunt, Ajjai Alva, Matthew T. Campbell, Vadim S. Koshkin
Topics & Concepts
MedicineInternal medicineOncologyUrothelial cancerMEDLINEClinical trialNeoplasm stagingPathologyChemotherapyNephrologyBladder and Urothelial Cancer TreatmentsEsophageal Cancer Research and TreatmentCancer, Lipids, and Metabolism